| Current Price | $40.14 | Mkt Cap | $1.7B |
|---|---|---|---|
| Open | $41.66 | P/E Ratio | 0.00 |
| Prev. Close | $40.14 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $40.09 - $41.69 | Volume | 286,305 |
| 52-Wk Range | $20.03 - $50.26 | Avg. Daily Vol. | 523,580 |
| Current Price | $40.14 | Mkt Cap | $1.7B |
|---|---|---|---|
| Open | $41.66 | P/E Ratio | 0.00 |
| Prev. Close | $40.14 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $40.09 - $41.69 | Volume | 286,305 |
| 52-Wk Range | $20.03 - $50.26 | Avg. Daily Vol. | 523,580 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about RGNX.
Recs
tking123
(72.47)
Submitted: 1/8/2021 12:55:00 PM :
Start Price:
$47.21
NASDAQ:RGNX Score:
-15.40
Small company targeting eye disease gene therapy. Its eye-disease treatment is being tested in people with wet age-related macular degeneration. This is a big market and the leaders are Roche and Regeneron Pharmaceuticals.....Keep an eye on this one.
Recs
findil
(97.91)
Submitted: 9/27/2018 12:08:01 PM :
Start Price:
$76.70
NASDAQ:RGNX Score:
-78.46
Love the optionality of partners and internal pipeline combined with a differentiated competitive advantage.
Recs
Bigsef77
(72.27)
Submitted: 9/14/2018 12:47:00 PM :
Start Price:
$77.85
NASDAQ:RGNX Score:
-85.05
Regenxbio (RGNX) has risen 121.35% YTD (year-to-date). Wall Street analysts expect it to report revenues of $194.55 million in 2018, which is a YoY (year-over-year) rise of 1,772.47%. Regenxbio expects license revenues in the second half of 2018 to be much lower than the first half of 2018 due to the non-recurring nature of those revenues.
Find the members with the highest scoring picks in RGNX.
otherAquanaut (99.81) Score: +232.80
The Score Leader is the player with the highest score across all their picks in RGNX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| otherAquanaut | 99.81 |
|
|
3M | $9.61 | +317.69% | +84.89% | +232.80 | 0 Comment | |
| portefeuille | 98.72 | 3/24/2016 |
|
5Y | $9.85 | +307.51% | +88.29% | +219.22 | 0 Comment | |
| portefeuille2 | 99.34 | 9/12/2016 |
|
5Y | $12.82 | +213.10% | +79.58% | +133.52 | 0 Comment | |
| clangmead | 55.26 | 9/12/2016 |
|
5Y | $12.82 | +213.10% | +79.58% | +133.52 | 1 Comment | |
| efarev | 91.43 | 5/23/2017 |
|
5Y | $18.60 | +115.81% | +58.91% | +56.90 | 0 Comment | |
| StockFlyer | 83.86 | 9/21/2020 |
|
5Y | $29.83 | +34.56% | +17.10% | +17.46 | 0 Comment | |
| TMFSaintCroix | 99.85 | 1/22/2018 |
|
5Y | $27.15 | +47.85% | +35.35% | +12.49 | 0 Comment | |
| Stlongs | 67.64 | 8/17/2020 |
|
5Y | $32.06 | +25.20% | +12.85% | +12.36 | 0 Comment | |
| MichaelDFS | 98.78 | 3/19/2020 |
|
1Y | $24.00 | +67.25% | +59.36% | +7.89 | 0 Comment | |
| Dananator | 50.32 | 11/19/2020 |
|
5Y | $36.76 | +9.19% | +7.17% | +2.02 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
